EP3558997
Amínó-triasólópýridín efnasambönd og notkun á þeim í meðferð krabbameina
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
19.12.2017EP published:
27.1.2021EP application number:
17825829.9
EP translation filed:
13.4.2021Grant published:
15.5.2021EPO information:
European Patent Register
Max expiry date:
18.12.2037Expiry date:
18.12.2026Next due date:
31.12.2026
Title:
AMINO-TRIAZOLOPYRIDINE COMPOUNDS AND THEIR USE IN TREATING CANCER
Timeline
Today
19.12.2017EP application
27.1.2021EP Publication
13.4.2021Translation submitted
15.5.2021Registration published
18.12.2026Expires
Owner
Name:
AstraZeneca ABAddress:
151 85 Södertälje, SE
Inventor
Name:
FINLAY, Maurice, Raymond, VerschoyleAddress:
Cambridge Cambridgeshire CB4 0FZ, GB
Name:
GOLDBERG, Frederick, WoolfAddress:
Cambridge Cambridgeshire CB4 0FZ, GB
Name:
TING, Attilla, Kuan, TsueiAddress:
Cambridge Cambridgeshire CB4 0FZ, GB
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201662436619 PDate:
20.12.2016Country:
US
Classification
Categories:
C07D 473/18, A61K 31/522, C07D 519/00, A61P 35/00
Annual fees
Number
Paid
Expires
Payer
Number: 5
Paid: 26.11.2021
Expires: 18.12.2022
Payer: Árnason Faktor ehf.
Number: 6
Paid: 9.11.2022
Expires: 18.12.2023
Payer: Árnason Faktor ehf.
Number: 7
Paid: 11.12.2023
Expires: 18.12.2024
Payer: Árnason Faktor ehf.
Number: 8
Paid: 5.11.2024
Expires: 18.12.2025
Payer: Árnason Faktor ehf.
Number: 9
Paid: 29.12.2025
Expires: 18.12.2026
Payer: Árnason Faktor ehf.